rs398122396
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_001257180.2(SLC20A2):c.1828_1831delTCCC(p.Ser610fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,612 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )
Consequence
SLC20A2
NM_001257180.2 frameshift
NM_001257180.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 10.0
Genes affected
SLC20A2 (HGNC:10947): (solute carrier family 20 member 2) This gene encodes a member of the inorganic phosphate transporter family. The encoded protein is a type 3 sodium-dependent phosphate symporter that plays an important role in phosphate homeostasis by mediating cellular phosphate uptake. The encoded protein also confers susceptibility to viral infection as a gamma-retroviral receptor. Mutations in this gene may play a role in familial idiopathic basal ganglia calcification. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0669 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-42417930-CGGGA-C is Pathogenic according to our data. Variant chr8-42417930-CGGGA-C is described in ClinVar as [Pathogenic]. Clinvar id is 75231.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC20A2 | NM_001257180.2 | c.1828_1831delTCCC | p.Ser610fs | frameshift_variant | 11/11 | ENST00000520262.6 | NP_001244109.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC20A2 | ENST00000520262.6 | c.1828_1831delTCCC | p.Ser610fs | frameshift_variant | 11/11 | 2 | NM_001257180.2 | ENSP00000429754.1 | ||
SLC20A2 | ENST00000342228.7 | c.1828_1831delTCCC | p.Ser610fs | frameshift_variant | 11/11 | 1 | ENSP00000340465.3 | |||
SLC20A2 | ENST00000520179.5 | c.1828_1831delTCCC | p.Ser610fs | frameshift_variant | 11/11 | 1 | ENSP00000429712.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461612Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 727114
GnomAD4 exome
AF:
AC:
1
AN:
1461612
Hom.:
AF XY:
AC XY:
1
AN XY:
727114
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SLC20A2-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 31, 2024 | The SLC20A2 c.1828_1831delTCCC variant is predicted to result in a frameshift and premature protein termination (p.Ser610Alafs*18). This variant occurs within the terminal exon of SLC20A2 and has been reported in nine members of a family presenting with idiopathic basal ganglia calcification (Family F2 in Hsu et al. 2013. PubMed ID: 23334463). Of note, an additional member of family F2 in Hsu et al. was reported as affected but did not have the variant. This variant has not been reported in a large population database, indicating this variant is rare. Frameshift variants in SLC20A2 are expected to be pathogenic and another truncating variant has been documented downstream of p.Ser610 (Hozumi et al. 2018. PubMed ID: 29627011). Based on this evidence, this variant is interpreted as pathogenic. - |
Idiopathic basal ganglia calcification 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at